FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to a method of adoptin cell therapy for preventing or treating infectious diseases caused by S.thyphimurium, L.monocytogenes.
EFFECT: invention provides effective treatment of diseases, caused by Salmonella thyphimurium, Listeria monocytogenes.
1 cl, 8 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING ANTI-TUMOR IMMUNOLOGICAL PROTECTION TO EL-4 LYMPHOMA CELLS | 2018 |
|
RU2708558C1 |
| LINE OF MICE TRANSGENIC ON AN ALPHA-CHAIN OF A T-CELL RECEPTOR OF MEMORY CELLS, TO STUDY THEIR FUNCTIONAL ACTIVITY | 2017 |
|
RU2691484C2 |
| ANTIGEN-SPECIFIC HELPER T-CELL RECEPTOR GENES | 2013 |
|
RU2680588C2 |
| METHOD FOR OBTAINING T-CELL RECEPTOR EXPRESSING CELLS | 2013 |
|
RU2665548C2 |
| SINGLE-DOMAIN LLAMA ANTIBODY H5 AND ITS DERIVATIVE H5-Fc SPECIFICALLY BINDING THE RBD DOMAIN OF THE S-PROTEIN OF THE SARS-CoV-2 VIRUS POSSESSING VIRUS-NEUTRALIZING ACTIVITY | 2022 |
|
RU2793967C1 |
| METHOD AND COMPOSITIONS FOR CELL IMMUNOTHERAPY | 2013 |
|
RU2700765C2 |
| COMPOSITIONS AND METHODS FOR TREATING HAEMOGLOBINOPATHIES | 2015 |
|
RU2707540C2 |
| LENTIVIRAL VECTORS FOR PKLR DELIVERY FOR TREATMENT OF PYRUVATE KINASE DEFICIENCY | 2018 |
|
RU2777934C2 |
| COMPOSITIONS AND METHODS FOR ENHANCING PKLR GENE EXPRESSION | 2017 |
|
RU2773358C2 |
| T CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS | 2013 |
|
RU2653761C2 |
